Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Istituto Europeo di Oncologia (IEO) is a premier non-profit comprehensive cancer center based in Milan, Italy, dedicated to the prevention, diagnosis, and treatment of cancer. Established in 1994 by Professor Umberto Veronesi, the institute operates as an IRCCS (Institute for Research, Hospitalization and Health Care), integrating clinical practice with cutting-edge translational research. IEO is internationally recognized for its leadership in breast cancer treatment, robotic surgery, and the development of innovative radiotherapy techniques. The center serves as a major hub for clinical trials in Europe, focusing on personalized medicine and the implementation of advanced genomic tools in oncology. Through its dedicated research center, IEO focuses on molecular oncology, genomic medicine, and the development of novel biomarkers to improve patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IEO.